Data from TCGA showed that, compared to normal adjacent tissue, breast cancers had a significantly increased expression of YBEY. However, metastatic disease (i.e., Stage IV) had significantly decreased YBEY expression compared with Stage I and II breast cancers. The gene discussed is YBEY; the disease is metastatic neoplasm.